Stock Evaluator: Raia Drogasil S.A. (RADLY)
Raia Drogasil S.A. RADLY
$2.72
0.00
0.00%
November 6, 2026 3:38:17 PM
EST
Volume: 10,418
After Hours: $120.37
0.15
|
0.12%
November 10, 2021 7:59 PM
EST
Volume: 72,713
USD
| DELAYED PRICE
| SECTOR | INDUSTRY |
| Consumer Staples | Consumer Staples Distribution & Retail |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Raia Drogasil S.A. engages in the retail sale of medicines, perfumery, personal care and beauty products, cosmetics and dermocosmetics and specialty medicines in Brazil. The company sells its products through stores, telesales, and call centers. Raia Drogasil S.A. was founded in 1905 and is headquartered in São Paulo, Brazil.
Financial Summary
| Share Statistics | RADLY | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $4,704.3 | $4,886.2 | 67% |
|
| Shares Out (Mil) | 322.4 | 100.9 | 83% |
|
| Institutional Ownership | 71.8% | 50.0% | 44% |
|
| Float (Mil) | 1,308.9 | 196.1 | 93% |
|
| Beta | 0.08 | 0.59 | 8% |
|
| Avg Daily Volume (000s) | 29 | 136 | 24% |
|
| Price Change (52-week) |
(25.0%) | 81.6% | 32% |
|
| Growth | RADLY | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 15.8% | 6.4% | 74% |
|
| Net Income (5yr) | 20.3% | 10.6% | 74% |
|
| EPS (5yr) | 21.8% | 11.6% | 71 |
|
| Dividends (5yr) | 0.0% | 0.0% | 53% |
|
| Cash Flow (5yr) | (15.2%) | (15.7%) | 50% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | na | na | |
| Current EPS | na | na | na | |
| Month Ago EPS | na | na | na | |
| # Rev Up | na | na | na | |
| # Rev Down | na | na | na | |
| Three Months Ago EPS | na | na | na | |
| Year/Year Chg | na | na | na | |
| Financials | RADLY | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $9,144 | $9,198 | 83% |
|
| Net Income (TTM) (Mil) | $250 | $214 | 70% |
|
| EPS (TTM) | $0.154 | $0.900 | 45% |
|
| Operating Cash Flow (TTM) (Mil) | $472 | $596 | 70% |
|
| Net Cash Flow (TTM) (Mil) | $12 | $6 | 58% |
|
| Long-Term Debt (Q1) (Mil) | $1,424 | $1,146 | 70% |
|
| Enterprise Value (Q1) (Mil) | $6,543 | $6,153 | 67% |
|
| Valuation | RADLY | Industry Median |
Percentile (All Stocks) |
|
| P/B | na | 3.18 | na |
|
| P/E | na | 20.4 | na |
|
| Dividend Yield | na | 0.0% | na |
|
| PEG (5yr hist) | na | 1.1 | na |
|
| Ratios | RADLY | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 30.9% | 23.9% | 36% |
|
| Net Margin | 2.7% | 2.5% | 39% |
|
| ROA | 5.3% | 4.8% | 72% |
|
| ROE | 18.1% | 15.9% | 76% |
|
| Liabilities to Assets | 70.5% | 67.8% | 66% |
|
| F-Score | na | 5 | na |
|
Raia Drogasil S.A. did not pass any screens on 11/6/2026.
